SCHEMBL14850486

SCHEMBL14850486

COc1cncc(-c2ccc(C)cn2)c1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.51
CYP2A6 P11509 1/20 0.51
CYP11B1 P15538 10/20 0.49
CYP11B2 P19099 9/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CCR1 P32246 1/20 0.48
CCR5 P51681 1/20 0.48
CCR8 P51685 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
CYP1A1 P04798 1/20 0.46
CYP1B1 Q16678 1/20 0.46
MKNK1 Q9BUB5 1/20 0.44
MKNK2 Q9HBH9 1/20 0.44
FYN P06241 3/20 0.43
CYP17A1 P05093 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
CYP2C19 P33261 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22454022 0.84 NPC1 (0.56) CYP3A4CYP2A6CYP1A2CYP2C9CCR1
SCHEMBL16835818 0.82 CYP11B1 (0.48) CYP3A4CYP11B1CYP11B2CYP1A2CYP2C9
SCHEMBL31403032 0.82 GRM5 (0.49) CYP3A4CYP11B1CYP11B2CYP1A2CYP2C9
SCHEMBL3422235 0.80 CYP2A6 (0.59) CYP3A4CYP2A6CYP11B1CYP11B2CCR1
SCHEMBL12019038 0.80 KDM1A (0.58) CYP3A4CYP2A6CYP1A2CCR1CCR5
SCHEMBL14848469 0.80 CYP11B1 (0.46) CYP3A4CYP11B1CYP11B2CYP1A2CYP2C9
SCHEMBL765406 0.79 RXFP1 (0.58) CYP3A4CYP2A6CYP11B1CCR1CCR5
SCHEMBL15296276 0.79 CYP11B1 (0.64) CYP3A4CYP11B1CYP11B2CYP1A2CYP2C9
SCHEMBL15344161 0.79 CYP2A6 (0.57) CYP3A4CYP2A6CYP11B1CYP11B2CYP1A2
SCHEMBL23905067 0.78 CYP11B1 (0.48) CYP3A4CYP2A6CYP11B1CYP11B2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2582676-B1 TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME (US) 2016-12-14 EP disclosed
US-8815902-B2 Tetrahydroquinoline amide M1 receptor positive allosteric modulators MERCK SHARP & DOHME CORP. (US) 2014-08-26 US disclosed
US-20130090352-A1 TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS MERCK SHARP & DOHME LLC 2013-04-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130090352-A1 TETRAHYDROQUINOLINE AMIDE M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS CHRM1, OPRL1, OPRM1 CYP3A4 709/4885CYP2A6 671/4885CYP11B1 1408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.